COVID 19 vaccinationand pregnancy
DOI:
https://doi.org/10.47196/diab.v56i3Sup.563Keywords:
pregnancy, vaccinationAbstract
SARS CoV-2 virus, a coronavirus detected in China in 2019, is the etiological agent of COVID 19, a pandemic that has generated a high impact in the world in terms of morbidity, mortality, socio-economic alterations and deterioration of the quality of life. life. Among the populations considered to be at high risk are pregnant people, a group in which a higher risk of severe forms, hospitalization and mortality have been observed.
Mass vaccination has proven to be the best strategy to reduce this impact. Having developed effective and safe vaccines, their use was recommended in all countries affected by the pandemic.
References
I. Actualización de los lineamientos técnicos. Resumen de recomendaciones vigentes para la Campaña Nacional de Vacunación contra la COVID-19. Dirección de Control de Enfermedades Inmnuoprevenibles. Ministerio de Salud. Febrero de 2022. Disponible en: https://bancos.salud.gob.ar/recurso/actualizacion-de-los-lineamientos-tecnicos-resumen-de-recomendaciones-vigentes-para-la
II. Wainstock T, Yoles I, Sergienko R, Sheiner E. Prenatal maternal COVID-19 vaccination and pregnancy outcomes. Vaccine 39 2021; 6037-6040. doi: 10.1016/j.vaccine.2021.09.012.
III. Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol 2022 Feb;226(2):177-186. doi: 10.1016/j.ajog.2021.08.054.
IV. Olson C. COVID-19 vaccine safety in pregnancy. Updates from the v-safe COVID-19 vaccine pregnancy registry Sep 22, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
